Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 739

1.

Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients.

Fu L, Li Z, Zhu J, Wang P, Fan G, Dai Y, Zheng Z, Liu Y.

Oncol Lett. 2016 Jul;12(1):269-274. Epub 2016 May 16.

PMID:
27347136
2.

Clinical relevance of circulating cell-free microRNAs in ovarian cancer.

Nakamura K, Sawada K, Yoshimura A, Kinose Y, Nakatsuka E, Kimura T.

Mol Cancer. 2016 Jun 24;15(1):48. doi: 10.1186/s12943-016-0536-0. Review.

3.

miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.

Shen CT, Qiu ZL, Song HJ, Wei WJ, Luo QY.

J Exp Clin Cancer Res. 2016 Jun 24;35(1):101. doi: 10.1186/s13046-016-0377-0.

4.

Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy.

Zhu Q, Qi H, Long Z, Liu S, Huang Z, Zhang J, Wang C, Dong L.

Sci Rep. 2016 Jun 23;6:28596. doi: 10.1038/srep28596.

5.

Profiling analysis of circulating microRNA expression in cervical cancer.

Nagamitsu Y, Nishi H, Sasaki T, Takaesu Y, Terauchi F, Isaka K.

Mol Clin Oncol. 2016 Jul;5(1):189-194. Epub 2016 Apr 25.

6.

Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.

Villard A, Marchand L, Thivolet C, Rome S.

J Mol Biomark Diagn. 2015 Nov;6(6). pii: 251. Epub 2015 Oct 2.

7.

Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.

Miguel V, Busnadiego O, Fierro-Fernández M, Lamas S.

Fibrogenesis Tissue Repair. 2016 May 10;9:7. doi: 10.1186/s13069-016-0044-2. eCollection 2016.

8.

Non-coding RNAs in muscle differentiation and musculoskeletal disease.

Ballarino M, Morlando M, Fatica A, Bozzoni I.

J Clin Invest. 2016 Jun 1;126(6):2021-30. doi: 10.1172/JCI84419. Epub 2016 Jun 1. Review.

PMID:
27249675
9.

Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Luo Z, Feng C, Hu P, Chen Y, He XF, Li Y, Zhao J.

Onco Targets Ther. 2016 May 4;9:2667-74. doi: 10.2147/OTT.S98408. eCollection 2016.

10.

Comparative Profiling of microRNA Expression in Soybean Seeds from Genetically Modified Plants and their Near-Isogenic Parental Lines.

Wang Y, Lan Q, Zhao X, Xu W, Li F, Wang Q, Chen R.

PLoS One. 2016 May 23;11(5):e0155896. doi: 10.1371/journal.pone.0155896. eCollection 2016.

11.

Biomarkers of risk to develop lung cancer in the new screening era.

Atwater T, Massion PP.

Ann Transl Med. 2016 Apr;4(8):158. doi: 10.21037/atm.2016.03.46. Review.

12.

MicroRNA in rectal cancer.

Azizian A, Gruber J, Ghadimi BM, Gaedcke J.

World J Gastrointest Oncol. 2016 May 15;8(5):416-26. doi: 10.4251/wjgo.v8.i5.416. Review.

13.

Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.

Endzeliņš E, Melne V, Kalniņa Z, Lietuvietis V, Riekstiņa U, Llorente A, Linē A.

Mol Cancer. 2016 May 18;15(1):41. doi: 10.1186/s12943-016-0523-5. Review.

14.

microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.

Hamam R, Ali AM, Alsaleh KA, Kassem M, Alfayez M, Aldahmash A, Alajez NM.

Sci Rep. 2016 May 16;6:25997. doi: 10.1038/srep25997.

15.

Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response.

Kwon OS, Kim KT, Lee E, Kim M, Choi SH, Li H, Fornace AJ Jr, Cho JH, Lee YS, Lee JS, Lee YJ, Cha HJ.

PLoS One. 2016 May 12;11(5):e0154942. doi: 10.1371/journal.pone.0154942. eCollection 2016.

16.

Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.

Becker S, Florian A, Patrascu A, Rösch S, Waltenberger J, Sechtem U, Schwab M, Schaeffeler E, Yilmaz A.

J Cardiovasc Magn Reson. 2016 May 6;18(1):25. doi: 10.1186/s12968-016-0244-3.

17.

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.

Bergman P, Piket E, Khademi M, James T, Brundin L, Olsson T, Piehl F, Jagodic M.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e219. doi: 10.1212/NXI.0000000000000219. eCollection 2016 Jun.

18.

Secreted microRNAs from tumor cells can suppress immune function.

Chen X, Liang H, Zen K, Zhang CY.

Oncoimmunology. 2016 Apr 8;5(4):e982407. eCollection 2016 Apr.

PMID:
27141407
19.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E627. doi: 10.3390/ijms17050627. Review.

20.

MicroRNAs and drug-induced kidney injury.

Pavkovic M, Vaidya VS.

Pharmacol Ther. 2016 Jul;163:48-57. doi: 10.1016/j.pharmthera.2016.03.016. Epub 2016 Apr 25. Review.

PMID:
27126472
Items per page

Supplemental Content

Write to the Help Desk